ADM stock holds focus after a year of earnings pressure

Archer Daniels Midland Company (US0394831020) remains a closely watched agribusiness name after fiscal 2025 revenue fell to $83.9 billion from $93.9 billion a year earlier, while adjusted EPS dropped to $3.16 from $5.20, according to the company's annual reporting. The shares last closed at a market value near the low end of recent trading ranges, leaving the stock tied to earnings recovery more than headline growth.

Revenue fell 10.7%

ADM reported fiscal 2025 revenue of $83.9 billion, down 10.7% from $93.9 billion in fiscal 2024, and adjusted EPS of $3.16, down 39.2% from $5.20 a year earlier. The comparison matters because it shows the scale of the reset before any new operating improvement can matter for valuation.

That earnings profile was built on a year that still produced large-scale commodity exposure, and the gap between revenue and profit trends remains the key investor lens. A smaller top line is not the only issue; the lower EPS indicates that margin compression also bit into the bottom line.

Margin still matters

The company's fiscal 2025 results show that ADM is still a margin story as much as a volume story. A business that generated $83.9 billion in annual revenue but only $3.16 in adjusted EPS in the same period leaves little room for disappointment in the next reporting cycle.

The year-on-year move from $93.9 billion to $83.9 billion also gives a clean reference point for any future rebound. If revenue stabilizes while earnings recover, the market will likely treat the margin path as the more important signal than the top-line comparison alone.

Animal nutrition stays relevant

One representative part of ADM's portfolio is animal nutrition, which sits inside a wider agribusiness mix that also includes oilseeds, carbohydrate solutions, and other ingredient operations. The segment detail matters because cyclical demand and input costs can shift the earnings mix even when annual revenue remains large.

For investors, the key question is whether ADM can turn its lower-earnings year into a base for better operating leverage. The next update will be judged against the same reference points: $83.9 billion in fiscal 2025 revenue, $3.16 in adjusted EPS, and the $93.9 billion and $5.20 comparison from fiscal 2024.

Trading near the bottom

ADM shares were recently priced at a market capitalization of about $30.6 billion, a level that reflects subdued sentiment versus the company's scale. With no fresh quote data in the body to anchor a live move, the most useful market marker is the valuation context itself.

That context is enough to show why the stock remains sensitive to even modest changes in margins or annual profit. A company with fiscal 2025 revenue of $83.9 billion and adjusted EPS of $3.16 does not need heroic growth to move sentiment, but it does need evidence that earnings are turning back up.

Nutrition products at work

ADM's nutrition and ingredient businesses remain central because they tie the company to everyday food, feed, and industrial demand. The product mix is not the story on its own, but it explains why annual report figures often matter more than single-day headlines for a stock like ADM.

Market value and venue

Archer Daniels Midland Company trades on the New York Stock Exchange under the symbol NYSE: ADM. The shares had a market capitalization of about $30.6 billion as of 16 July 2026, and that valuation frames the company as a large, slower-moving earnings recovery story rather than a growth rerating candidate.